skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Vitamin D deficiency in HIV-infected patients: a systematic review

Review

(937) Views  (670) Full article downloads

Authors: Giusti A, Penco G, Pioli G

Published Date November 2011 Volume 2011:3 Pages 101 - 111
DOI: http://dx.doi.org/10.2147/NDS.S6921

Andrea Giusti1, Giovanni Penco2, Giulio Pioli3
1Bone Clinic, Department of Gerontology and Musculoskeletal Sciences, Galliera Hospital, Genoa, Italy; 2Department of Infectious Diseases, Galliera Hospital, Genoa, Italy; 3Department of Geriatrics, ASMN Hospital, Reggio Emilia, Italy

Abstract: Advances in the diagnosis and management of human immunodeficiency virus (HIV) have resulted in a dramatic decrease in mortality in HIV-infected individuals (HIV+). The subsequent increase in life expectancy of HIV+ has led to the need to consider the long-term complications of the disease and its treatment. Abnormalities in vitamin D status and metabolism are increasingly recognized as a major concern in HIV infection. In the last 5 years a number of cross-sectional and prospective studies have suggested a high prevalence of vitamin D deficiency in HIV+. Although few case-control studies have been published, it has been suggested that the prevalence of hypovitaminosis D in HIV+ is higher than in the general population, and at least in part, is related to the course of the disease and/or the antiretroviral drugs used to treat the disease. An adequate vitamin D status is important not only for bone tissue, but also for the global health status of HIV+ individuals, since a growing body of evidence has demonstrated the detrimental effects of vitamin D deficiency on multiple health outcomes. Therefore, definition of the size of the problem and identification of effective protocols for the prevention and management of vitamin D deficiency in HIV+ patients represent important steps in improving health status and reducing long-term chronic complications in individuals with HIV. Due to its immunomodulatory effects, vitamin D may also have implications in the progression of HIV infection. This systematic review was designed to determine the prevalence of vitamin D deficiency in HIV+ patients; to identify risk factors (related to the HIV infection or not) potentially associated with this condition; to describe the potential consequences of hypovitaminosis D on the course of the infection and the benefits of vitamin D repletion; and to make some suggestions about the future, considering the limitations of previous studies.

Keywords: human immunodeficiency virus, HIV, vitamin D, parathyroid hormone, bone, antiretroviral







Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Folic acid supplementation for the prevention of neural tube defects: promotion and use
Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions
Prenatal nutritional influences on obesity risk in offspring
Mediterranean diet and polyamine intake: possible contribution of increased polyamine intake to inhibition of age-associated disease
Use of dietary supplements among US adults with asthma
Clinical potential for the use of probiotics in the management of respiratory conditions and cold- and influenza-like symptoms
Atypical eating disorders: a review
Successful long-term weight loss maintenance in a rural population
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University